02 January, 2009 |
| 11:18 |
Seasons Greetings |
A. D'Emanuele |
10 February, 2009 |
| 16:08 |
[RegAffairs]Proposal of Alternate Manufacturing Site-CANADA |
kams |
16 February, 2009 |
| 06:01 |
[RegAffairs]Clinical Trials in Latin America |
Vardhini Kirthivas |
17 February, 2009 |
| 08:47 |
[RegAffairs]Objectionable organisms |
Brian MATTHEWS |
24 February, 2009 |
| 17:23 |
[RegAffairs]Regulatory Compliance Issues in PharmaceuticalOutsourcing |
prasanna |
25 February, 2009 |
| 07:37 |
[RegAffairs]RE: Regulatory Compliance Issues in PharmaceuticalOutsourcing |
Ketan Agravat |
| 10:18 |
[RegAffairs]New Drug Withdrawal |
prasanna |
| 11:37 |
[RegAffairs]RE: New Drug Withdrawal |
Stein Lyftingsmo |
26 February, 2009 |
| 09:05 |
[RegAffairs]Re: New Drug Withdrawal |
Malcolm Ross |
05 March, 2009 |
| 12:18 |
[RegAffairs]Re: SUPAC guidelines for Europe |
Malcolm Ross |
| 12:50 |
[RegAffairs]SUPAC guidelines for Europe |
akkineni lakshmi |
| 16:54 |
[RegAffairs]Re: SUPAC guidelines for Europe |
Steve Binysh (business) |
| 17:56 |
[RegAffairs]RE: SUPAC guidelines for Europe |
ramasamy venkatasamy |
| 17:57 |
[RegAffairs]Re: SUPAC guidelines for Europe |
Brian Matthews |
08 April, 2009 |
| 07:02 |
[RegAffairs]Manufacturing license in EU countries |
akkineni lakshmi |
| 09:22 |
Re: [RegAffairs]Manufacturing license in EU countries |
Brian MATTHEWS |
| 10:36 |
[RegAffairs]Re: Manufacturing license in EU countries |
Tim Felgate |
| 13:51 |
[RegAffairs]Re: Manufacturing license in EU countries |
akkineni lakshmi |
| 13:51 |
[RegAffairs]Re: Manufacturing license in EU countries |
Bfn |
09 April, 2009 |
| 07:01 |
[RegAffairs]Safety Assessment |
Maria Ines Harris |
| 09:47 |
[RegAffairs]Re: Safety Assessment |
Adriaan Fruijtier |
| 14:54 |
[RegAffairs]Re: EU supac |
shakeel |
25 April, 2009 |
| 13:11 |
[RegAffairs]Japan DMF & Dossier filing |
Yoganantham A [ Regulatory Affairs ] |
| 14:30 |
[RegAffairs]Re: Japan DMF & Dossier filing |
Brian MATTHEWS |
27 April, 2009 |
| 06:22 |
[RegAffairs]Re:Japan DMF & Dossier filing |
B.Anil Kumar Singh |
28 April, 2009 |
| 08:24 |
[RegAffairs]Re: Japan DMF & Dossier filing |
shakeel.salam |
04 May, 2009 |
| 09:22 |
[RegAffairs]Change in API source |
prasanna sagar |
| 12:07 |
[RegAffairs]Re: Change in API source |
Brian MATTHEWS |
| 12:35 |
[RegAffairs]Re: Change in API source |
Globepharm /Consulting |
05 May, 2009 |
| 08:13 |
[RegAffairs]Stability studies for ANDA submission |
Harikishan |
| 09:15 |
[RegAffairs]Ophthalmic formulations: Drop size requirement |
Harikishan |
| 13:33 |
[RegAffairs]Re: Stability studies for ANDA submission |
shakeel |
| 13:34 |
[RegAffairs]RE: Stability studies for ANDA submission |
Aravind |
| 16:24 |
[RegAffairs]RE: Ophthalmic formulations: Drop size requirement |
Steve Binysh |
06 May, 2009 |
| 09:06 |
[RegAffairs]ANVISA - OTC Registration Requirements |
Harikishan |
| 10:21 |
[RegAffairs]RE: Change in API source |
Aravind |
| 14:17 |
[RegAffairs]Re: ANVISA - OTC Registration Requirements |
Maria Ines Harris |
12 May, 2009 |
| 08:26 |
[RegAffairs]Re: ANVISA - OTC Registration Requirements |
Harikishan |
| 12:04 |
[RegAffairs]CEP source and Test method |
Kams |
| 13:14 |
[RegAffairs]FDA inquiry |
Bojan Pavlovic |
15 May, 2009 |
| 18:32 |
[RegAffairs]Polymorphism |
mei azhakan |
16 May, 2009 |
| 07:39 |
[RegAffairs]Re: Polymorphism |
N.Sumithra |
| 10:37 |
[RegAffairs]Re: Polymorphism |
B.Anil Kumar Singh |
| 20:27 |
[RegAffairs]Re: FDA inquiry |
Globepharm /MAnisfeld |
18 May, 2009 |
| 08:47 |
[RegAffairs]First Three Validation Batches for US Market |
NIRAV CHOKSHI |
| 17:46 |
[RegAffairs]RE: First Three Validation Batches for US Market |
Globepharm /MAnisfeld |
| 18:30 |
[RegAffairs]Re: First Three Validation Batches for US Market |
cgmpman |
27 May, 2009 |
| 09:19 |
[RegAffairs]SOP |
anandgd |
| 10:18 |
[RegAffairs]Clinical Trial |
Prasoon Mishra |
| 11:24 |
[RegAffairs]Re: Clinical Trial |
lt09 |
| 12:28 |
[RegAffairs]Re: Clinical Trial |
Tim Felgate |
29 May, 2009 |
| 16:59 |
[RegAffairs]Outsourcing of technical services and regulatoryrequirements |
L Watson |
01 June, 2009 |
| 05:41 |
[RegAffairs]EU GMP certification |
Praveen Kumar |
| 09:14 |
[RegAffairs]Re: EU GMP certification |
B.Anil Kumar Singh |
| 10:18 |
[RegAffairs]Re: EU GMP certification |
Ketan Agravat |
| 13:27 |
[RegAffairs]Re: EU GMP certification |
Sharma, Lalit |
| 17:00 |
[RegAffairs]Re: EU GMP certification |
lt09 |
02 June, 2009 |
| 07:13 |
[RegAffairs]Waiver for bioequivalence - ophthalmic products |
Harikishan |
04 June, 2009 |
| 11:40 |
[RegAffairs]Puerto Rico Guidelines |
shakeel.salam |
| 19:23 |
[RegAffairs]Re: Puerto Rico Guidelines |
Globepharm /MAnisfeld |
05 June, 2009 |
| 22:15 |
[RegAffairs]How to export nutritional Supplements to EU ? |
Michal Kranc |
07 June, 2009 |
| 09:05 |
[RegAffairs]Re: How to export nutritional Supplements to EU ? |
Steve Binysh |
| 12:45 |
[RegAffairs]Re: How to export nutritional Supplements to EU ? |
Wanda Jay |
| 19:00 |
[RegAffairs]Stability testing |
Stein |
| 20:25 |
[RegAffairs]RE: Stability testing |
Rivka Zaibel |
| 22:02 |
[RegAffairs]RE: Stability testing |
Lassoff, Peter |
| 22:02 |
[RegAffairs]RE: Stability testing |
Steve Binysh |
08 June, 2009 |
| 15:31 |
[RegAffairs]RE: Stability testing |
Peter Geffen |
14 June, 2009 |
| 16:22 |
[RegAffairs]Re: ANVISA - OTC Registration Requirements |
Maria Ines Harris |
20 June, 2009 |
| 10:01 |
[RegAffairs]Re: stability indicating method |
rajamaniiyer |
| 10:19 |
[RegAffairs]stability indicating method |
saravanan |
| 13:07 |
[RegAffairs]Re: Stability indicating method |
Jim Tyrrell |
| 22:07 |
[RegAffairs]Re: stability indicating method |
Malcolm Ross |
22 June, 2009 |
| 10:33 |
[RegAffairs]RE: stability indicating method |
Sreejith Kurup |
13 July, 2009 |
| 09:17 |
[RegAffairs]Microbial testing frequency for solutions |
akkineni lakshmi |
| 18:21 |
[RegAffairs]Residual Metal Catalyst |
harshath |
| 18:21 |
[RegAffairs]Polymorphism |
Mei |
| 21:15 |
[RegAffairs]Re: Polymorphism |
Malcolm Ross |
18 July, 2009 |
| 12:41 |
Re: [RegAffairs]Polymorphism |
Muthiah Saravanan |
21 July, 2009 |
| 12:41 |
[RegAffairs]Stability - Assay Parameter |
Jain |
| 13:43 |
[RegAffairs]Re: Stability - Assay Parameter |
Muthiah Saravanan |
| 14:43 |
[RegAffairs]Re: Stability - Assay Parameter |
Ranjith Gamage |
| 15:01 |
[RegAffairs]Re: Stability - Assay Parameter |
Malcolm Ross |
| 15:15 |
[RegAffairs]Re: Stability - Assay Parameter |
Brian MATTHEWS |
| 15:59 |
[RegAffairs]Recreating clinical data |
Malcolm Ross |
| 16:45 |
[RegAffairs]RE: Recreating clinical data |
Lassoff, Peter |
| 18:28 |
[RegAffairs]Re: Recreating clinical data |
Vincent Wek |
| 18:33 |
[RegAffairs]Re: Recreating clinical data |
Steve Binysh (business) |
| 20:14 |
[RegAffairs]Re: Recreating clinical data |
Malcolm Ross |
22 July, 2009 |
| 06:44 |
[RegAffairs]Re: Recreating clinical data |
Steve Binysh (business) |
23 July, 2009 |
| 21:18 |
[RegAffairs]Expiry or provisional expiry |
Kalpana Pandey |
24 July, 2009 |
| 07:42 |
[RegAffairs]RE: Expiry or provisional expiry |
akkineni lakshmi |
| 08:42 |
[RegAffairs]Re: Expiry or provisional expiry |
Muthiah Saravanan |
| 18:49 |
[RegAffairs]Re: Expiry or provisional expiry |
Malcolm Ross |
| 18:49 |
[RegAffairs]Re: Stability - Assay Parameter |
Kams |
| 18:49 |
[RegAffairs]Re: Expiry or provisional expiry |
Sharma, Lalit |
| 19:49 |
[RegAffairs]osmolarity as IP test |
prasanna sagar |
| 19:49 |
[RegAffairs]Re: Expiry or provisional expiry |
Steve Binysh (business) |
| 19:53 |
[RegAffairs]Re: Expiry or provisional expiry |
VISHAL |
| 22:25 |
[RegAffairs]Re: Expiry or provisional expiry |
Brian MATTHEWS |
